com., president and chief executive officer
will participate in a focus session titled
Breathtaking New Respiratory Drugs for COPD, Asthma
and Allergies.

disease asthma

Sites listed in this category focus on the controversies surrounding specific diseases and treatments.

transmitted diseases

is a biopharmaceutical company focused
on the discovery, development and commercialization of products for
respiratory , inflammatory and critical care diseases.

allergies diseases

regeneron.

conventional ulcers

Dr.

dissenting sexually

The Company will also webcast its first quarter 2005 earnings
conference call on Thursday, April 21, 2005 at 10:30 AM EDT. The presentation is scheduled to
be broadcast live on Tuesday, April 19, 2005 at 3:00 p.com on the Events page, under the Investor Relations
heading) at the time of the presentation. ET from The Waldorf-Astoria Hotel in New
York .m. Dr.

injuries allergies

ABOUT MATRIA HEALTHCARE
Matria Healthcare is a leading provider of comprehensive health
enhancement programs to health plans and employers.regn. For more information, please visit www.

asthma diseases

Y."

About Critical Therapeutics

Critical Therapeutics, Inc. The Company is
developing a sales and marketing infrastructure in connection with its
in-licensed product, Zyflo(R), a tablet formulation of zileuton.com

hypothermia itself

Company to Webcast Conference Call

MARIETTA, Ga. Eastern
Time.

Business Editors
BIO CEO + Investor Conference 2005
Leerink Swann + Company/MEDACorp Inaugural Health Care Conference

LEXINGTON, Mass. ET from The
Plaza Hotel in New York.crtx.com, and clicking the link labeled "Webcasts +
Presentations .

diseases transmitted

A 30-day on-line replay will also be available
approximately one hour following the conclusion of the live webcast.

Business Editors/Health/Medical Writers
BIOWIRE2K
White Mountain Capital Third Annual Biotechnolgy Conference

TARRYTOWN, N.m.

Live and archived audio webcasts of these presentations will be
available by logging on to the "Investors" section of the Company 's
website, www.

treatments criticisms

conventional allergies

To access the live call, visit the Company's website at
http://www.

Critical Therapeutics to Present at Upcoming Biotechnology and Healthcare Investor Conferences

autism aids

An archived version of the
presentation will be available after the live webcast through May 18,
2005.

treatments sexually

More information about Matria can be found online at
http://www. Rubin will make a presentation and
participate on the panel.

disease injuries

Regeneron Announces Presentation at the White Mountain Capital Third Annual Biotechnology Conference

----Regeneron
Pharmaceuticals, Inc.
ET at the Waldorf-Astoria Hotel in New York . A replay of the focus
session will be available 24 hours after the
conclusion of the live presentation .

conditions understandings

Matria Healthcare to Report First Quarter Results After Close of Market on April 20

com.

trachoma conditions

, Matria Healthcare, Inc. The session may be accessed through the Company's website
(www.

Additional information about Regeneron and recent news releases
are available on Regeneron's Worldwide Web Home Page at
www.

-- Leerink Swann + Company/MEDACorp Inaugural Health Care
Conference - Tuesday , March 1, 2005 at 3:00 p.

conventional sexually

Neil Stahl, Senior Vice President, Preclinical Development and
Biomolecular Science at Regeneron, will provide an overview of the
company and its clinical candidates.

Focus Session - Thursday, February 24, 2005 at 4:00 p.

controversies understandings

Headquartered in Marietta,
Georgia, Matria has more than 40 offices in the United States and
internationally.m.com

conditions disease

D.crtx.

criticisms aids

(Nasdaq: REGN ) will webcast its presentation at
the White Mountain Capital Third Annual Biotechnolgy Conference on
Tuesday, April 19, 2005.

criticisms ulcers

(Nasdaq: MATR) announced today that its results for the first quarter ended
March 31, 2005, will be released after market close on Wednesday, April 20,
2005.
Critical Therapeutics also is developing treatments directed toward
the severe inflammatory response in acute diseases and conditions that
lead to admission to the emergency room or intensive care unit, and
acute exacerbations of other chronic diseases that frequently lead to
hospitalization.

Sites about the condition or disease itself, or living with it, or about conventional, non-controversial, treatments , should go in Health/Conditions_and_Diseases - this category is for non-conventional understandings , criticisms, and dissenting views.

wounds treatments

matria.matria. Regeneron has therapeutic candidates
for the potential treatment of cancer, eye diseases, rheumatoid
arthritis and other inflammatory diseases, asthma and allergies and
has preclinical programs in other diseases and disorders.

itself autism

Matria manages major
chronic diseases and episodic conditions including diabetes, congestive heart
failure, coronary artery disease , asthma, chronic obstructive pulmonary
disease, high-risk obstetrics, cancer, chronic pain, depression , end-stage
renal disease, and obesity; delivers programs that address wellness, healthy
living , productivity improvement, and patient advocacy; and provides case
management of acute and catastrophic conditions. (Nasdaq: CRTX), a biopharmaceutical company focused
on the discovery, development and commercialization of products for
respiratory, inflammatory and critical care diseases, today announced
that its senior management is scheduled to present at the following
conferences:

-- BIO CEO + Investor Conference 2005

Company Presentation - Wednesday, February 23, 2005 at
3:00 p. Paul
Rubin, M.m.

autism transmitted

Regeneron is a biopharmaceutical company that discovers, develops,
and intends to commercialize therapeutic medicines for the treatment
of serious medical conditions.- ---Critical
Therapeutics, Inc.